Ventricular Tachycardia and Ventricular Fibrillation

Ventricular Tachycardia (V Tach)

  • Definition: Ventricular tachycardia is an abnormal heart rhythm that originates from the ventricles. This abnormality occurs due to an abnormal electrical signal from the heart's conduction system, causing rapid contractions of the ventricles.

  • It mostly happens when the SA node and the AV node fails to generate impulse, causing the ventricles to be pacing the heart

  • Cardiac Output: Due to the rapid contraction, the ventricles cannot pump blood effectively, leading to a decrease in cardiac output and the possibility of VF which is life threatening

  • Duration: V tach can be short (intermittent) or sustained. For instance, it may occur with a series of premature ventricular contractions (PVCs) noted as three or more in succession.

Characteristics of Ventricular Tachycardia

  • QRS Complex:

    • Hallmark finding is a widened QRS complex (greater than 0.120.12 seconds) that looks bizarre and is distinctive for V tach.

    • Heart Rate: The ventricular rate is rapid, ranging from 100100 to 250250 beats per minute.

    • Rhythm Regularity: The rhythm is typically regular.

    • Visibility of Other Waves: P waves and T waves are often not assessable; thus, atrial rates, rhythms, or PR intervals cannot be determined.

  • Visual Aspects: The defining characteristic of V tach is its distinctively wide and regular QRS complex, with no visibility of P waves or T waves, emphasizing the rapid ventricular activity.

  • Presentations:

    • Monomorphic V Tach: Displays consistent appearance throughout the rhythm.

    • Polymorphic V Tach: Presents variation in appearance throughout the rhythm.

    • Example of Polymorphic V Tach: Torsades de pointes, a specific type of polymorphic V tach.

Causes of Ventricular Tachycardia

  • Electrolyte Imbalances: Notably hypokalemia (low potassium levels) can lead to V tach.

  • Myocardial Infarction: Damage to heart tissue affects electrical conduction, potentially leading to arrhythmias.

  • Medication Toxicity: Drugs such as digoxin (DIG) toxicity can provoke V tach.

  • Heart Diseases: Conditions including heart failure, coronary artery disease, and valve diseases are contributing factors.

Causes for Polymorphic V Tach (e.g., Torsades de Pointes)
  • QT Interval Prolongation: Medications that prolong the QT interval, such as amiodarone, sotalol, or procainamide, may trigger this type of V tach.

  • Electrolyte Levels: Low levels of calcium, magnesium, or potassium can contribute to this arrhythmia.

Signs and Symptoms

  • Chest pain

  • Oxygen saturation is low

  • Lethargic

  • Anxiety

  • Palpitations

  • Shortness of breath

  • Elevated heart rate

  • Dizziness or syncope fainting

Treatment of Ventricular Tachycardia

Assess patient patient and if:

  • Medication Options:

    • Stable Patient: If the patient is stable with a good pulse, antiarrhythmic medications like intravenous amiodarone can be administered. If unsuccessful, synchronized cardioversion should be considered.(50 to 200joules or depending on the device recommendation

    • Unstable Patient: If the patient displays symptoms (e.g., hypotension, chest pain) but retains a pulse, synchronized cardioversion is necessary to restore normal rhythm along with antiarrhythmics like amiodarone.

    • No Pulse/Unresponsive Patient: Begin CPR immediately, incorporating chest compressions, defibrillation, and administering epinephrine while securing the airway. Use drugs like amiodarone or lidocaine as indicated.

  • Polymorphic V Tach Treatment: Administer magnesium sulfate and cease any medications that prolong the QT interval. For unstable patients or those with no pulse, follow procedures similar to V fib treatment.

  • Post-Resuscitation Care: After successful return to a normal rhythm, a patient may require an implanted cardioverter defibrillator (ICD) to prevent future arrhythmias.

Ventricular Fibrillation (V Fib)

  • Definition: V fib is a deadly rhythm originating from the ventricles. It results in a quivering of the ventricles rather than effective contractions and consequently leads to a significant drop in cardiac output.

  • Characteristics:

    • The rhythm appears chaotic and rapid

    • Unknown or undistinguishable

    • Due to this irregular activity, P waves, QRS complexes, T waves, and PR intervals cannot be identified.

    • The ECG strip showcases coarse fibrillatory waves in V fib.

Causes of Ventricular Fibrillation

  • Heart Conditions: Severe heart diseases or myocardial infarctions can trigger V fib due to ischemia and subsequent heart muscle damage.

  • Electrolyte Imbalances: Significant fluctuations in potassium levels (either low or high) can lead to arrhythmias.

  • Hypoxia: Low oxygen levels in the blood can instigate V fib, often linked to respiratory diseases.

  • Drug Overdose: Certain drug overdoses may lead to the development of V fib. Eg digoxin

  • Unsuccessfully treated v tachycardia

Signs and symptoms

Mostly patient are unconscious with this rhythm

But can also exhibit

  • Chest pain

  • Low oxygen saturation

  • Lethargy

  • Anxiety

  • Palpitations

  • Shortness of breath

  • Dizziness

Treatment of Ventricular Fibrillation

  • Emergency Protocol: V fib is a life-threatening condition requiring immediate treatment; the patient will be unresponsive and without a pulse.

    • Immediate Actions: Activate the emergency response system, initiate CPR, and employ ACLS protocols.

    • Medications: Provide chest compressions, perform defibrillation, and administer medications like epinephrine, amiodarone, or lidocaine while maintaining airway security.

  • Consideration for Future Treatment: If resuscitated, the potential for needing an ICD to prevent recurrence of V fib should be assessed.

Conclusion

  • Understanding and effectively treating ventricular tachycardia and ventricular fibrillation are critical due to their potential life-threatening implications. The recognition of symptoms, timely intervention, and the appropriate use of emergency protocols and medications can significantly impact patient outcomes.